Chemicals - Specialty

The ₹3,030 crore BHAVYA Rasayan scheme, along with three newly notified greenfield chemical parks, provides direct fiscal and infrastructure support to expand domestic specialty chemicals manufacturing. This policy framework is designed to reduce import dependence and attract fresh investment across the value chain. Over a 2-5 year horizon, these initiatives are expected to meaningfully increase installed capacity and improve supply-chain self-sufficiency.

Global manufacturers are actively reducing single-country supplier concentration, creating sustained demand for Indian specialty chemical producers as alternative sources. India's competitive cost structure, improving regulatory environment, and growing technical capabilities position it to capture a larger share of global chemical procurement. This structural shift is expected to drive volume growth and new customer relationships over the medium to long term.

The India-UK trade agreement and advancing India-EU FTA negotiations raise the prospect of lower tariffs and zero-duty access for a meaningful share of Indian specialty chemical exports to two of the world's largest import markets. Improved market access could enhance price competitiveness and support higher export volumes for domestic producers. Rules-of-origin details remain a key variable that will determine the magnitude of the benefit.

Rising investment in battery materials, exemplified by Himadri Speciality Chemical's ₹1,300 crore capex plan, reflects a structural shift toward higher-value specialty adjacencies tied to the energy transition. Demand for anode materials, electrolyte chemicals, and related inputs is expected to grow rapidly as India scales domestic electric vehicle and energy storage manufacturing. This creates a long-duration growth runway for producers that successfully diversify into advanced materials.

M&A activity such as Indo Borax's proposed ₹246.12 crore acquisition of a 64.26% stake in Kronox Lab Sciences signals an ongoing consolidation trend in niche specialty segments. Consolidation can improve pricing power, reduce fragmentation, and enable acquirers to offer broader product portfolios to customers. Over time, this dynamic is likely to benefit larger, well-capitalised players at the expense of sub-scale competitors.

Specialty chemical producers remain exposed to fluctuations in key raw material costs such as sulphur, petrochemical derivatives, and specialty intermediates, which can compress margins even when revenues grow. DMCC Speciality Chemicals' FY26 results illustrated this dynamic, with revenue growth offset by margin compression driven by commodity realisation swings. Sustained input cost pressure could limit the translation of volume growth into earnings improvement.

Excess manufacturing capacity in China continues to result in competitively priced exports that pressure Indian producers in both domestic and third-country markets. Chinese producers benefit from scale, integrated supply chains, and, at times, state support, making it difficult for Indian firms to compete purely on price in commoditised specialty segments. This structural competitive threat requires Indian companies to continuously move up the value chain.

Tightening environmental norms domestically and in export destination markets are increasing compliance costs for specialty chemical manufacturers, particularly for effluent treatment, emissions control, and hazardous waste management. Smaller players may struggle to absorb these costs, while larger firms face capital allocation trade-offs between compliance investment and growth capex. Regulatory divergence across markets also adds complexity for exporters.

While the India-UK and India-EU trade agreements have generated positive sentiment, the actual benefit to specialty chemical exporters depends heavily on rules-of-origin provisions that are still being negotiated or clarified. If origin requirements are stringent, many products may not qualify for preferential tariff treatment, limiting the competitive uplift. This uncertainty delays investment decisions tied to export market expansion.

Scaling into higher-value specialty segments requires deep R&D capabilities and a pipeline of trained chemical engineers and scientists, areas where India still faces structural gaps relative to global leaders. Insufficient investment in domestic research infrastructure and talent development could constrain the sector's ability to move beyond process chemistry into proprietary product innovation. Bridging this gap requires sustained collaboration between industry, academia, and government.